Filing Details
- Accession Number:
- 0001298711-24-000011
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-06-11 20:33:45
- Reporting Period:
- 2024-06-11
- Accepted Time:
- 2024-06-11 20:33:45
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1711279 | Krystal Biotech Inc. | KRYS | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1298711 | Suma Krishnan | C/O Krystal Biotech, Inc. 2100 Wharton Street, Suite 701 Pittsburgh PA 15203 | President, R&D | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-06-11 | 900 | $171.40 | 1,549,982 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-06-11 | 2,099 | $172.24 | 1,547,883 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-06-11 | 1,206 | $173.41 | 1,546,677 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-06-11 | 1,724 | $174.50 | 1,544,953 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-06-11 | 4,975 | $175.33 | 1,539,978 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-06-11 | 5,867 | $176.38 | 1,534,111 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-06-11 | 6,358 | $177.38 | 1,527,753 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-06-11 | 1,871 | $178.14 | 1,525,882 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-06-11 | 1,100 | $171.49 | 1,611,162 | No | 4 | S | Indirect | By Spouse |
Common Stock | Disposition | 2024-06-11 | 1,882 | $172.21 | 1,609,280 | No | 4 | S | Indirect | By Spouse |
Common Stock | Disposition | 2024-06-11 | 1,318 | $173.49 | 1,607,962 | No | 4 | S | Indirect | By Spouse |
Common Stock | Disposition | 2024-06-11 | 4,000 | $174.83 | 1,603,962 | No | 4 | S | Indirect | By Spouse |
Common Stock | Disposition | 2024-06-11 | 4,550 | $175.76 | 1,599,412 | No | 4 | S | Indirect | By Spouse |
Common Stock | Disposition | 2024-06-11 | 5,705 | $176.68 | 1,593,707 | No | 4 | S | Indirect | By Spouse |
Common Stock | Disposition | 2024-06-11 | 5,447 | $177.68 | 1,588,260 | No | 4 | S | Indirect | By Spouse |
Common Stock | Disposition | 2024-06-11 | 998 | $178.36 | 1,587,262 | No | 4 | S | Indirect | By Spouse |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Indirect | By Spouse |
No | 4 | S | Indirect | By Spouse |
No | 4 | S | Indirect | By Spouse |
No | 4 | S | Indirect | By Spouse |
No | 4 | S | Indirect | By Spouse |
No | 4 | S | Indirect | By Spouse |
No | 4 | S | Indirect | By Spouse |
No | 4 | S | Indirect | By Spouse |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 90,000 | Indirect | By SMK Trust |
Common Stock | 50,000 | Indirect | By Krishnan Family Trust |
Footnotes
- The sales reported were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The Rule 10b5-1 trading plan started on September 11, 2023, and contemplated quarterly sales of 25,000 shares with a limit price of $100.00 per share. The Rule 10b5-1 trading plan has reached the maximum number of shares to be sold under such plan and has terminated.
- The transaction was executed in multiple trades ranging from $170.75 to $171.74. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The transaction was executed in multiple trades ranging from $171.84 to $172.81. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The transaction was executed in multiple trades ranging from $172.85 to $173.80. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The transaction was executed in multiple trades ranging from $173.85 to $174.83. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The transaction was executed in multiple trades ranging from $174.85 to $175.83. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The transaction was executed in multiple trades ranging from $175.85 to $176.83. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The transaction was executed in multiple trades ranging from $176.85 to $177.80. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The transaction was executed in multiple trades ranging from $177.85 to $178.48. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The sales reported were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person's spouse, Krish S. Krishnan. The Rule 10b5-1 trading plan started on September 11, 2023, and contemplated quarterly sales of 25,000 shares with a limit price of $100.00 per share. The Rule 10b5-1 trading plan has reached the maximum number of shares to be sold under such plan and has terminated.
- These same shares are also being reported on a Form 4 by the Reporting Person's spouse, Krish S. Krishnan.
- Directly beneficially owned by Krish S. Krishnan, the spouse of the Reporting Person.
- The transaction was executed in multiple trades ranging from $171.83 to $172.76. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The transaction was executed in multiple trades ranging from $172.85 to $173.81. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The transaction was executed in multiple trades ranging from $174.21 to $175.19. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The transaction was executed in multiple trades ranging from $175.21 to $176.20. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The transaction was executed in multiple trades ranging from $176.21 to $177.19. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The transaction was executed in multiple trades ranging from $177.21 to $178.11. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The transaction was executed in multiple trades ranging from $178.24 to $178.48. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- Directly beneficially owned by the Krishnan Family Trust. The Reporting Person and her spouse are each joint beneficial owners of the trust with joint voting and investment control.